Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.54 USD | -3.13% | +3.34% | +143.76% |
07-10 | Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating | MT |
07-09 | Guggenheim Adjusts Price Target on Insmed to $95 From $70, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+143.76% | 12.57B | |
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03